CURhE (Consortium for Universal Rh disease Elimination) Company Profile

04:47 EDT 17th September 2019 | BioPortfolio

News Articles [1406 Associated News Articles listed on BioPortfolio]

SYNGO Consortium releases public data resource for universal reference in synapse research

(Broad Institute of MIT and Harvard) Disruptions to the brain's synapses lie at the root of many disorders. The international SYNGO Consortium, which brings together 15 laboratories and the Gene Ontol...

Alzheimer’s Consortium to Study Eisai, BioArctic Treatments for Disease Prevention

The Alzheimer’s Clinical Trials Consortium (ACTC) will assess Eisai’s elenbecestat in a pair of upcoming clinical trials studying prevention of early stages of the memory-robbing disease—inc...

A path to universal health coverage in America

Thirteen years ago, as a student in New York City, I marched across the Brooklyn Bridge to implore my colleagues to fight for universal health care. That day, I enunciated what has become my personal ...

An overview of the WIN consortium

Prof Schilsky speaks with ecancer about the overarching mission of the WIN consortium. He begins by outlining the successes so far coming out of the WIN consortium since its conception, including the...

US Measles Cases at Second-Highest Since Elimination in 2000

The number of individual measles cases is at its second highest in the United States since its elimination in 2000, according to the latest data from the Centers for Disease Control and Prevention. ...

Four European Countries Lose Measles Elimination Status

Four countries in the European Union — Albania, Czechia, Greece, and the U.K. — have lost their measles elimination status based on disease transmission in 2018, the...

NEJM applying universal standards of care to Ebola virus disease

(Liverpool School of Tropical Medicine) LSTM's Senior Clinical Lecturer, Dr. Shevin Jacob, is corresponding author on a perspective piece published in the New England Journal of Medicine calling for u...

Universal standards of care to Ebola virus disease

Medical researchers are calling for universal standards of care to be applied in relation to Ebola virus disease.

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Nitrogen [ucg georgia, llc]


Oxygen [ala med dba pulmonary care services]


Levetiracetam [ncs healthcare of ky, inc dba vangard labs]

Levetiracetam Tablets Rx OnlyRevised: March, 2011

Engerix-b [dispensing solutions inc.]

ENGERIX-B Hepatitis B Vaccine (Recombinant)

Metvixia™ (methyl aminolevulinate) cream, 16.8%for topical use only. not for ophthalmic, oral, or intravaginal usemust be dispensed to and applied by a physician. [penn pharmaceutical services ltd.]

METVIXIA™ (methyl aminolevulinate) Cream, 16.8%For Topical Use Only. Not for Ophthalmic, Oral, or Intravaginal UseMust be dispensed to and applied by a physician.

PubMed Articles [3254 Associated PubMed Articles listed on BioPortfolio]

The rheumatic heart disease healthcare paradox: disease persistence in slums despite universal healthcare coverage-a provider perspective qualitative study.

Rheumatic heart disease (RHD) is a preventable disease frequently recognized in urban slums. Disease rates in Brazilian slums are incommensurate with the country's economic status and the existence of...

Epidemiology of Kawasaki disease before and after universal Bacille Calmette-Guérin vaccinations were discontinued.

Bacille Calmette-Guérin (BCG) vaccine (BCG) has been suggested to induce the primary immunity needed for the subsequent Kawasaki disease (KD). We studied the epidemiology of KD before and after the u...

The Progressive Multifocal Leukoencephalopathy Consortium as a Model for Advancing Research and Dialogue on Rare Severe Adverse Drug Reactions.

Progressive multifocal leukoencephalopathy (PML) is a rare but serious disease. Caused by the JC virus (JCV), it occurs in individuals with weakened immune systems and is a potential adverse reaction ...

The experience and challenges of healthcare-reform-driven medical consortia and Regional Health Information Technologies in China: A longitudinal study.

To achieve universal access to medical resources-a partial goal of the second ambitious health reform since 2010-the Chinese government aimed to build a regional medical consortium and enhance the eff...

Degradation of Bisphenol S by a Bacterial Consortium Enriched from River Sediments.

The widespread use of bisphenol S (BPS) as a bisphenol A substitute increases its potential of release into the aquatic environments. However, the degradation of BPS in aquatic systems is largely un...

Clinical Trials [4131 Associated Clinical Trials listed on BioPortfolio]

Linkage Consortium for End-Stage Renal Disease

The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic ...

36-Month Clinical Evaluation of a Universal Adhesive

The aim of this clinical trial was to evaluate and compare the performance of a universal adhesive with different adhesive strategies in the restoration of non-carious cervical lesions (NC...

Eosinophilic Esophagitis (EoE) Intervention Trial-Randomized 1 Food Elimination vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids

The purpose of this interventional study is to test and compare the effectiveness of two elimination diets—the 1-food elimination diet (1FED, milk only) and the 4-food elimination diet (...

Universal CD19-CART Treating ALL

Universal CART(U-CART) has a great advantage for its allogeneic T cell resource. After gene disruption of TCRα and HLA-1, U-CART will exempt from immunologic rejection by the receptor, an...

Clinical Comparison of Universal Adhesives in Terms of Different Application Modes on the Restoration of NCCLs

The aim of this randomized, controlled, prospective clinical trial was to evaluate the performances of two different universal adhesives and an etch&rinse adhesive in restoration of non-ca...

Companies [1294 Associated Companies listed on BioPortfolio]

CURhE (Consortium for Universal Rh disease Elimination)

Consortium for Plasma Science LLC

The Consortium for Plasma Science, LLC, was formed in January 1997 to support the development of a universal approach to eradicate pathogens in whole blood plasma. The Consortium is cofunded by Alpha ...

Arizona Alzheimer's Consortium

The Arizona Alzheimer's Consortium is a laboratory without walls designed to leverage the strengths of its seven member institutions to promote the scientific understanding of Alzheimer's disease. The...

Nitrate Elimination Co Incorporated

Nitrate Elimination Co., Inc. (NECi) makes enzymes (natural and recombinant) for environmental cleanup: nitrate testing, enzymatic nitrate elmination, and nitrate biocatalytic microsensors.

Universal Protection Service

Founded in 1965, Universal Protection Service (UPS) combines an innovative mix of tradition with cutting edge systems and technology to keep pace with the ever-evolving needs of today's business envir...

More Information about "CURhE (Consortium for Universal Rh disease Elimination)" on BioPortfolio

We have published hundreds of CURhE (Consortium for Universal Rh disease Elimination) news stories on BioPortfolio along with dozens of CURhE (Consortium for Universal Rh disease Elimination) Clinical Trials and PubMed Articles about CURhE (Consortium for Universal Rh disease Elimination) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CURhE (Consortium for Universal Rh disease Elimination) Companies in our database. You can also find out about relevant CURhE (Consortium for Universal Rh disease Elimination) Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record